The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...
The Scheme of Arrangement was approved by the New Delhi Bench of the NCLT under the provisions of the Companies Act, 2013.
Mankind Pharma has received a ₹183.11 crore tax demand from the Income Tax Department for AY 2014-15 to 2017-18 due to ...
Discover an intriguing stock idea with Mankind Pharma showing signs of a rebound and potential upside in price action.
2d
ET Now on MSNMankind Pharma Amalgamation: Latest update on merger with 3 subsidiaries – DetailsEarlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...
The NSE Nifty 50 ended 72.60 points or 0.31% lower at 23,519.35, while the BSE Sensex closed 191.51 points, or 0.25% down at ...
Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...
The Nifty Pharma index closed on a positive note on Friday. Shares of Mankind Pharma Ltd.(up 7.59 per cent), Ajanta Pharma ...
AM(IST)on Friday in an upbeat market. Mankind Pharma Ltd.(up 5.07 per cent), Ajanta Pharma Ltd.(up 3.62 per cent), Sun ...
Despite the recent correction, the number of Rs1 lakh crore-plus market cap firms has slightly increased between the end of FY24 and early FY25. For perspective, FY23 and FY22 each recorded 48 ...
Photograph: Kind courtesy Mankind Pharma/Facebook.com Mankind Pharma, India's fourth-largest drug firm by market share, plans to come up with its generic version of Novo Nordisk's blockbuster anti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results